A Look Ahead: Predictions for the Life Sciences in 2026
Biocompare published a forward-looking article examining the trends expected to shape the life sciences industry in 2026, featuring insights from industry leaders across discovery and development. Among the contributors, Lars Hartvig Kristiansen highlights the growing shift toward human-relevant disease models, including advanced 3D cell culture systems and organoids, as a critical step toward improving the predictivity of preclinical research. He also underscores the role of automation and AI-enabled workflows in enabling the scale, consistency, and reproducibility needed to translate complex biology into actionable insights. Together, these perspectives point to a future where more physiologically relevant models and intelligent technologies help accelerate drug discovery and improve decision-making earlier in development.